Norman A W, Nemere I, Zhou L X, Bishop J E, Lowe K E, Maiyar A C, Collins E D, Taoka T, Sergeev I, Farach-Carson M C
Division of Biomedical Sciences, University of California Riverside 92521.
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):231-40. doi: 10.1016/0960-0760(92)90349-n.
The hormonally active form of vitamin D is 1,25(OH)2-vitamin D3 [1,25(OH)2D3]. This seco-steroid is the key mediator of the vitamin D endocrine system which produces biological effects in over 28 target tissues. In these target tissues, the biological responses may be generated both by a signal transduction mechanism which involves a nuclear receptor for 1,25(OH)2D3 that modulates gene transcription or a signal transduction pathway which involves rapid opening of Ca2+ channels which are externally located on the plasma membrane. This paper reviews the evidence in support of the pleiotropic effects of this steroid hormone and presents evidence that the receptor of the genomic effects is likely to be separate from the receptor/membrane recognition element which initiates the rapid nongenomic biological effects.
维生素D的激素活性形式是1,25(OH)2-维生素D3 [1,25(OH)2D3]。这种甾体激素是维生素D内分泌系统的关键介质,它在超过28种靶组织中产生生物学效应。在这些靶组织中,生物学反应可能通过两种信号转导机制产生:一种涉及1,25(OH)2D3核受体的信号转导机制,该受体调节基因转录;另一种是涉及质膜外侧Ca2+通道快速开放的信号转导途径。本文综述了支持这种甾体激素多效性作用的证据,并提出证据表明基因组效应的受体可能与启动快速非基因组生物学效应的受体/膜识别元件不同。